Alembic Pharmaceuticals informs about disclosure

10 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, Alembic Pharmaceuticals has informed that the Company has acquired Series Seed Preferred Stock of RIGlmmune, Inc. In this regard, the company enclosed a press release. The detailed disclosure pursuant to Regulation 30(2) of the aforesaid Regulations is also enclosed as Annexure-1.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

770.85 7.95 (1.04%)
23-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1732.20
Dr. Reddys Lab 1307.00
Cipla 1326.10
Zydus Lifesciences 907.90
Lupin 2245.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×